The Astrazeneca PLC Board have announced an interim dividend of $1.97 per share (145.3 pence, 18.00 SEK) has been declared, meaning a full-year dividend per share of $2.87 (210.1 pence, 25.77 SEK).
Other financial highlights include:
In Q4 2021, Total Revenue increased 62% (63% CER) to $12,011m
Reported EPS of $0.08 (FY 2020: $2.44) and Core EPS of $5.29 (FY 2020: $4.02)
FY 2022 guidance at CER of a high-teens percentage increase in Total Revenue and a mid-to-high twenties percentage increase in Core EPS
